Louisiana BioHistory

Learn about the scientists behind the discoveries, entrepreneurs,
political leaders, and significant events, people and institutions that are the foundation
of the biotechnology, medical device, pharmaceutical and life science industries
in the state of Louisiana.

Tell us about Louisiana's BioHistory. If you are aware of a notable event, person,
organization/company or accomplishment that we should include,
please e-mail: BioHistory@InfoResource.org

1834 -- The Medical College of Louisiana (Tulane University) founded.

Tulane University was founded as the Medical College of Louisiana in 1834 in New Orleans, making it the second oldest medical college in the Deep South. In 1847, the Medical College became part of a newly established public institution, the University of Louisiana, but in 1884 the university was reorganized and Tulane University was privatized through a donation by Paul Tulane, a wealthy merchant who made his fortune in New Orleans.

Today the university enrolls over 10,000 students and is organized into 10 schools, including the School of Medicine, the School of Public Health and Tropical Medicine, and the School of Science and Engineering. Tulane is one of the country's leading research institutions and is home to several research centers including the Tulane National Primate Research Center, the Tulane University Health Sciences Center, the Tulane Cancer Center, and the Tulane Center for Gene Therapy.

1848 -- American Association for the Advancement of Science founded.

American Association for the Advancement of Science founded in 1848 marked the emergence of a national scientific community in the United States, and was the first organization established to promote the development of science and engineering at the national level and to represent the interests of all its disciplines.

Today, the AAAS serves nearly 300 affiliated societies and academies of science and publishes the peer-reviewed general science journal Science. The non-profit AAAS is open to all and fulfills its mission to "advance science and serve society" through initiatives that include science policy, international programs, science education, and public understanding of science.

1859 -- Charles Darwin published "The Origin of Species."

In 1859, British naturalist Charles Darwin published "On the Origin of Species by Means of Natural Selection, or the Preservation of Favoured Races in the Struggle for Life" in which he postulated his theory of evolution that explained how the diverse of species on Earth evolved from a simple, singled-celled ancestor.

From 1831-1836, Darwin served as a naturalist aboard the H.M.S. Beagle -- a British science expedition around the world. In South America Darwin discovered fossils of extinct animals that were similar to modern species, and on the Galapagos Islands, located west of Equador, he noticed many variations of plants and animals of the same general type as those in South America. Throughout the expedition Darwin studied plants and animals and collected specimens for further study.

Upon his return to London, Darwin conducted thorough research of his notes and specimens, and out of his study grew several related theories: evolution did occur; evolutionary change was gradual, requiring thousands to millions of years; the primary mechanism for evolution was a process called natural selection; and the millions of species alive today arose from a single original life form through a branching process called "specialization."

Darwin's theory of evolutionary selection holds that variation within species occurs randomly and that the survival or extinction of each organism is determined by that organism's ability to adapt to its environment. Darwin's theory of evolution remains the foundation of modern biology.

Suggested Reading:

1859 -- The Seminary of Learning of the State of Louisiana (Louisiana State University) founded.

Louisiana State University was founded in 1859 near Pineville as the Seminary of Learning of the State of Louisiana. In 1865, the seminary burned down and was reopened in 1869 in Baton Rouge where it remains to this day. In 1877, the university merged with the Louisiana State Agricultural & Mechanical College, a land-grant institution. Today, LSU is one of only thirteen American universities designated as a land-grant, sea-grant, and space-grant research center.

LSU enrolls over 30,000 students and offers 72 degree programs. It has nine senior colleges and four schools, including the School of Basic Sciences, the School of Veterinary Medicine, and the College of Agriculture. Each year the University receives more than $120 million in research grants and conducts more than 2,500 sponsored research projects.

1865 -- Gregor Mendel, the father of modern genetics, presents his laws of heredity.

1887 -- Marine Hospital Service Hygienic Laboratory (National Institutes of Health) founded.

The National Institutes of Health (NIH) traces its roots to 1887, when a one-room laboratory was created within the Marine Hospital Service (MHS), predecessor agency to the U.S. Public Health Service (PHS). The MHS was established in 1798 to provide for the medical care of merchant seamen -- charged by Congress with examining passengers on arriving ships for clinical signs of infectious diseases, such as cholera and yellow fever, to prevent epidemics.

During the 1870s and 1880s, scientists in Europe presented compelling evidence that microscopic organisms were the causes of several infectious diseases, and MHS officials closely followed these developments. In 1887, Joseph Kinyoun, a MHS physician trained in the new bacteriological methods, set up a one-room laboratory in the Marine Hospital at Stapleton, Staten Island, New York. Kinyoun called this facility a "laboratory of hygiene" in imitation of German facilities, and within a few months, he identified the cholera bacillus and used his Zeiss microscope to demonstrate it to his colleagues as confirmation of their clinical diagnoses.

The Biologics Control Act enacted in 1902 had major consequences for the Hygienic Laboratory. It charged the laboratory with regulating the production of vaccines and antitoxins, making it a regulatory agency four years before passage of the 1906 Pure Food and Drugs Act. The danger posed by biological products that had emerged from bacteriologic discoveries resulted from their production in animals and their administration by injection. In 1901, thirteen children in St. Louis died after receiving diphtheria antitoxin contaminated with tetanus spores. This tragedy spurred Congress to pass the Biologics Control Act, and between 1903-1907 standards were established and licenses issued to pharmaceutical firms for making smallpox and rabies vaccines, diphtheria and tetanus antitoxins, and various other antibacterial antisera. (In 1972, responsibility for regulation of biologics was transferred to the Food and Drug Administration). (Photo: courtesy of the NIH Almanac)

In 1912 MHS was reorganized, renamed the Public Health Service (PHS) and authorized to conduct research into noncontagious diseases and into the pollution of streams and lakes in the U.S. During World War I, the PHS attended primarily to sanitation of areas around military bases in the U.S., and when the 1918 influenza pandemic struck Washington, physicians from the laboratory were pressed into service treating patients in the District of Columbia because so many local doctors had fallen ill. In 1930, the Ransdell Act changed the name of the Hygienic Laboratory to the National Institute of Health (NIH) and authorized the establishment of fellowships for research into basic biological and medical problems. The roots of this act extended to 1918, when chemists who had worked with the Chemical Warfare Service in World War I sought to establish an institute in the private sector to apply fundamental knowledge in chemistry to problems of medicine. In 1937, the National Cancer Institute (NCI) was created with sponsorship from every Senator in Congress, and was authorized to award grants to nonfederal scientists for research on cancer and to fund fellowships at NCI for young researchers.

During World War II, the NIH focused almost entirely on war-related problems. At the close of the war, PHS leaders guided through Congress the 1944 Public Health Service Act, which defined the shape of medical research in the post-war world. Two provisions were especially important: 1) In 1946 the NCI grants program was expanded to the entire NIH, and the program grew from just over $4 million in 1947, to more than $100 million in 1957, and to $1 billion in 1974. The entire NIH budget expanded from $8 million in 1947 to more than $1 billion in 1966, now fondly remembered as "the golden years" of NIH expansion. Accompanying growth in the grants program was the proliferation of new categorical institutes, and from 1946-1949, voluntary health organizations moved Congress to create institutes for research on mental health, dental diseases, and heart disease. In 1948, language in the National Heart Act made the name of the umbrella organization the National Institutes of Health. 2) The 1944 PHS Act authorized NIH to conduct clinical research, and after the war Congress provided funding to build a research hospital, now called the Warren Grant Magnuson Clinical Center on the NIH campus in Bethesda, Maryland. The Center which opened in 1953 with 540 beds was designed to bring research laboratories into close proximity with hospital wards in order to promote productive collaboration between laboratory scientists and clinicians. (Photo: National Archives and Records Administration photograph, courtesy of the Franklin Delano Roosevelt Library, Hyde Park, New York)

The NIH today, part of the U.S. Department of Health and Human Services, is the primary Federal agency for conducting and supporting medical research and is composed of 27 Institutes and Centers, providing leadership and financial support to researchers in every state and throughout the world.

1918 -- Spanish Influenza Pandemic.

It is estimated that between 25 and 40 million people died from the the influenza outbreak that began in 1918, swept across America in a week and around the world in three months. In all, between 500,000 and 700,000 Americans --civilians and soldiers-- died from the influenza, more than were lost in World War I, II, and the Korean and Viet Nam wars combined.

Latest Findings: In September 2004, the National Institutes of Health (NIH) awarded a five-year, $12.5 million grant to five institutions that will collaborate to study genes constructed from 1918 flu-virus particles salvaged from the bodies of World War I soldiers and the exhumed Brevig Mission, Alaska resident. The Institutions include the Armed Forces Institute of Pathology, Washington, D.C.; Mount Sinai School of Medicine, New York; Scripps Research Institute, La Jolla, CA; the Centers for Disease Control and Prevention; and the University of Washington. The ultimate goal is to use knowledge gained from the study to develop vaccines, influenza medications and diagnostic tests to prevent a similar influenza outbreak.

Suggested Reading:

1933 -- Thomas Hunt Morgan awarded Nobel Prize in Physiology or Medicine for his chromosome theory of heredity.

1947 -- Transistor invented at AT&T's Bell Laboratories.

The transistor, the invention that marked the dawn of the information age, was invented by John Bardeen, William Shockley and Walter Brattain at AT&T's Bell Laboratories. Bardeen, Shockley and Brattain were awarded the 1956 Nobel Prize in Physics for their discovery of the transistor effect.

Transistors have become an invisible technology that is part of almost every electronic device. Every major information age innovation was made possible by the transistor and its application can be found all around us. (Photos: © The Nobel Foundation)

1953 -- Double helix structure of DNA revealed.

The double helix structure of DNA, the hereditary molecule is revealed by two scientists, James D. Watson and Francis Crick. This is one of the key discoveries of the century. Watson and Crick shared the 1962 Nobel Prize for Physiology and Medicine with Maurice Wilkins for their discoveries concerning the molecular structure of nuclear acids and its significance for information transfer in living material.

Rosalind Franklin, whose work contributed to the discovery, died before this date and the rules do not allow a Nobel Prize to be awarded posthumously. (Photos: © The Nobel Foundation)

Suggested Reading:

1958 -- Integrated circuit invented.

1961 -- President John F. Kennedy expands U.S. Space Program

1969 -- Man walks on the moon.

An important benefit of the Apollo Lunar Program and other NASA programs is the ever-growing pipeline of technology that improves human and veterinary healthcare diagnostics and therapeutics.

1969 -- Victor McKusick publishes "Mendelian Inheritance in Man".

Victor McKusick, widely acknowledged as the father of medical genetics, spent his career studying the genetic basis of diseases and disorders with the belief that such an understanding could lead to new methods of diagnosis and treatment. He studied, identified, and mapped genes responsible for inherited conditions such as Marfan syndrome and dwarfism (specifically in Amish communities). In 1969, he proposed the idea of mapping the human genome, over 30 years before the Human Genome Project was established.

McKusick, a graduate of Johns Hopkins (M.D. 1946), spent his entire career there and founded the Division of Medical Genetics in 1957, the first research center and clinic of its kind. In 1969 he published the 1st edition of his book "Mendelian Inheritance of Man", one of the most comprehensive collections of inherited disease genes. In 2002, McKusick received the highest scientific honor in the U.S., the National Medal of Science.

1971 -- NASDAQ Stock Market founded.

Nasdaq, founded February 8, 1971, is now the largest U.S. electronic stock market. With approximately 3,300 companies, it lists more companies and, on average, trades more shares per day than any other U.S. market. NASDAQ is home to companies that are leaders across all areas of business including technology, retail, communications, financial services, transportation, media, biotechnology, medical device, and pharmaceutical.

Suggested Reading:

1973 -- Recombinant DNA perfected.

1974 -- Employee Retirement Income Security Act of 1974 (ERISA).

John N. Erlenborn, the ranking Republican on the House Committee, was responsible for bringing the Employee Retirement Income Security Act of 1974 (ERISA) to a floor vote, and is one of the ERISA’s "Founding Fathers." Together with Senator Jacob Javits (R-NY), Senator Pete Williams (D-NJ) and Congressman John Dent (D-PA), Erlenborn crafted provisions and participated in negotiations that were instrumental to the enactment of ERISA which was - and remains - the single most important legislation governing employee benefit plans in the United States providing an important source of financial investment for the stock market. (Photos: Jacob Javits and Pete Williams courtesy U.S. Senate Historical Office).

1975 -- Monoclonal antibodies produced.

In 1975, Georges Köhler and César Milstein, showed how monoclonal antibodies can be generated by isolating individual fused myeloma cells.

The 1984 Nobel Laureate in Medicine was awarded jointly to: Niels Jerne, Georges Köhler and César Milstein for theories concerning the specificity in development and control of the immune system and the discovery of the principle for production of monoclonal antibodies. (Photos: © The Nobel Foundation)

1976 -- Genentech, founder of the biotechnology industry, established.

In 1976, Genentech was founded by venture capitalist Robert Swanson and biochemist Dr. Herbert Boyer. In the early 1970s, Boyer and geneticist Stanley Cohen at Stanford University pioneered recombinant DNA technology. Excited by the breakthrough, Swanson called Boyer who agreed to give the young entrepreneur 10 minutes of his time. Swanson's enthusiasm for the technology resulted in a three hour meeting and at its conclusion, Genentech was born.

Within a few short years Swanson and Boyer invented a new industry - biotechnology. In 1980, Genentech issued its Initial Public Offering (IPO) and raised $35 million with an offering that jumped from $35 a share to a high of $88 after less than an hour on the market. The event was one of the largest stock run-ups ever, and that event set the stage for future biotechnolgy industry offerings.

Genentech was initially broadly focused in three areas including food processing, industrial chemicals, and human health care. In 1982, Eli Lilly & Co. which had acquired worldwide rights to Genenetch's recombinant human insulin (1978) received FDA approval to market the product -- the first biotechnology therapeutic to reach the marketplace.

Beginning in 1983, Genentech became solely focused on human therapeutics and diagnostics, and in 1985, Genentech received approval from FDA to market its first product, Protropin® (somatrem for injection) growth hormone for children with growth hormone deficiency — the first recombinant pharmaceutical product to be manufactured and marketed by a biotechnology company. In 1990, Genentech and Roche Holding Ltd. of Basel, Switzerland completed a $2.1 billion merger. Today, Genentech is among the world's leading biotech companies with multiple protein-based products on the market for serious or life-threatening medical conditions.

1977 -- First human gene cloned.

Walter Gilbert induced bacteria to synthesize insulin and interferon, and Frederick Sanger published the complete sequence of phage FX174. The 1980 Nobel Laureate in Chemistry was awarded jointly to Frederick Sanger and Walter Gilbert for "for their contributions concerning the determination of base sequences in nucleic acids, and to Paul Berg for his fundamental studies of the biochemistry of nucleic acids, with particular regard to recombinant-DNA. (Photos: © The Nobel Foundation)

1977 -- Andrew Schally awarded Nobel Prize in Physiology or Medicine.

1980 -- U.S. Supreme Court ruled man-made organism patentable.

1980 -- Bayh-Dole Act provides for university technology transfer.

1986 -- Biomedical Research Foundation of Northwest Louisiana founded.

Biomedical Research Foundation of Northwest Louisiana (BRF) is an independent, nonprofit, 501(c)(3) organization established in 1986 that supports four initiatives: InterTech Science Park for life science and related technologies; Positron Emission Tomography Imaging Center and Southern Isotopes; Education and Workforce Development programs; and the Louisiana State University Health Sciences Center in Shreveport (LSUHSC-S).

The Foundation was originally founded through a recommendation from the Mt. Auburn Study, an economic development report that identified new initiatives to diversify the Shreveport-Bossier economy. Today, the BRF has 51 employees and a volunteer board of directors that manages a $13 million operating budget and $63 million in assets.

1990 -- Human Genome Project established.

The U.S. Human Genome Project was established -- a 13-year effort coordinated by the U.S. Department of Energy and the National Institutes of Health. The project, originally planned to last 15 years, was expected to be completed by 2003 due to rapid technological advances.

1993 -- Biotechnology Industry Organization (BIO) founded.

Biotechnology Industry Organization is the world's largest organization to serve and represent the biotechnology industry. BIO's leadership and service-oriented guidance have helped advance the industry and bring the benefits of biotechnology to people everywhere.

1993 -- Kary B. Mullis awarded Nobel Prize in Chemistry.

1994 -- Virginia K. Shehee Biomedical Research Institute founded.

Virginia K. Shehee Biomedical Research Institute, founded in 1994, is a 10-story, 160,000 square foot research facility with 56 state-of-the-art labs currently occupied by scientists and researchers from Louisiana State University Health Sciences Center in Shreveport. The Institute houses more than 250 researchers, technicians and support personnel working to find cures to such diseases as stroke, cancer, arthritis and Alzheimer's.

The Institute is named for Virginia K. Shehee who ranks high among Louisiana's most revered business leaders and community benefactors. The growth and accomplishments of the Biomedical Research Foundation of Northwest Louisiana from 1986–1996 were due in large part to her leadership and tenacity. She has been a guiding force in the development of the Biomedical Research Foundation from a community vision to a budding science/technology center with $64 million in assets. In addition to laboratories, the Institute is home to the Biomedical Research Foundation’s administrative offices and the PET Imaging Center.

2000 -- Louisiana Gene Therapy Research Consortium founded.

Louisiana Gene Therapy Research Consortium (LGTRC), founded in 2000, is a partnership among Louisiana’s public and private health sciences centers including: Louisiana State University Health Sciences Centers in New Orleans and Shreveport, and Tulane University Health Sciences Center in New Orleans. The Consortium began with a State Legislature appropriation of $45 million to support recruitment of leading researchers in the cell and gene therapy field, establish core technology labs at the sites of member institutions, and develop cell and gene therapy technologies for clinical applications.

To date, the Consortium has received approximately $20 million, with $13 million dedicated for building a Clinical Manufacturing Facility and the other $7 million for attracting researchers and building and equipping core research laboratories. Additionally, the LGTRC has successfully recruited top researchers, leveraged $60 million in Federal Grants, and has generated 22 gene therapy research projects, 19 pre-clinicals in animals, 4 patent applications, and one start-up company. The LGTRC also has a 22,000 sq. ft. FDA compliant clinical manufacturing facility under construction that will accomodate DNA plasmid, viral vector, and somatic cell production techniques. Customers for the manufacturing facility will be academic research institutions, cell therapy companies, and gene therapy companies.

2001 -- Human Genome Project draft sequence published.

2002 -- Louisiana Cancer Research Consortium of New Orleans founded.

Louisiana Cancer Research Consortium of New Orleans (LCRC), was created in 2002 during a Special Session of the Louisiana State Legislature that provided a structure in which Tulane University Health Sciences Center and Louisiana State University Health Sciences Center - the state's two leading medical research institutions - will work together and coordinate cancer research development in preparation for recognition as a National Cancer Institute Designated Cancer Center.

The LCRC is funded by a legislatively enacted 12-cent increase in the tax on a pack of cigarettes, three cents of which would fund infrastructure and cancer research program development for the new Consortium. Conservative estimates indicate that approximately $10 million per year will be generated from this revenue source.

Other Resources

Other State & Province BioHistories

Other Life Science History Resources

Tell us about Louisiana's BioHistory. If you are aware of a notable event, person,
organization/company or accomplishment that we should include,
please e-mail: BioHistory@InfoResource.org